Read more
Informationen zum Autor Dr. Douglas Goodin, director of the Multiple Sclerosis Center at UCSF Medical Center, is a neurologist and an internationally renowned expert in the treatment and research of multiple sclerosis.. He earned a bachelor of sciences degree in genetics and biochemistry at the University of Washington in Seattle; a master of sciences degree in molecular biology at Purdue University in Indiana; and a medical degree from the University of California, Irvine. He completed a residency in neurology at UCSF where he joined the medical center staff in 1982. In addition to multiple sclerosis, Goodin's research interests include various forms of dementia. Goodin also is a professor of neurology at UCSF. Klappentext An Exploration into China's Economic Development and Electricity Demand by the Year 2050, is an exploratory study of national and regional economic development, energy demand and electricity demand in China by the year of 2050. China's economy grows rapidly and it is now the second largest economy in the world. In 2010, GDP reached 40 trillion Yuan and electricity consumption was second only to the United States, reaching 4.19 trillion kWh. Many people follow future (long-term) trends of Chinese economic development and demand for electricity closely and are especially interested in how development will look in 2030 and 2050. Based on the ILE4, this book examines the main features of China's economic development and electricity consumption since the economic reform of the 1980's. It includes an analysis of the intrinsic connection between electricity demand and economic growth and the changing trends of the adjustment of economic structure, regional layout optimization and development of the energy intensive industry, as well as how these factors impact China's demand for electricity. In addition, the book considers the next 20 years of China's economic development and growing demand for electricity based on the detailed simulations conducted by ILE4 in regional economic development and electricity consumption in 2030 as well as the prospective of China's electricity consumption and economic growth in the year 2050. Multiple Sclerosis (MS) is generally understood to be an inflammatory autoimmune disease of the central nervous system. This title includes chapters on key topics including the genetics of MS, MRI imaging and MS, and the treatment options. Inhaltsverzeichnis Section 1 Pathogenesis 1. Immune regulation of multiple sclerosis 2. Neuropathology of MS 3. The good and the bad of neuroinflammation in multiple sclerosis 4. Demyelination in multiple sclerosis 5. Axonal loss in multiple sclerosis: Causes and mechanisms 6. Insights from magnetic resonance imaging 7. Infections and multiple sclerosis 8. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment Section 2 Epidemiology and genetics 9. Multiple sclerosis genetics 10. Genetics of primary progressive multiple sclerosis 11. The epidemiology of multiple sclerosis: insights to disease pathogenesis Section 3 Diagnosis and disease course 12. Multiple Sclerosis: Diagnosis, differential diagnosis and clinical presentation 13. MRI mimics of multiple sclerosis 14. Diagnosis of multiple sclerosis 15. Clinical course of multiple sclerosis 16. Early prognosis of multiple sclerosis 17. Clinical outcome measures in multiple sclerosis 18. MRI outcomes in the diagnosis and disease course of multiple sclerosis 19. Multiple sclerosis in children Section 4 Treatment 20. Clinical trials in multiple sclerosis 21. Glucocorticoid treatment of multiple sclerosis 22. Disease modifying agents in multiple sclerosis 23. Immunosuppressive treatments in multiple sclerosis 24. Symptomatic treatment and manageme...
List of contents
Section 1 Pathogenesis
1. Immune regulation of multiple sclerosis
2. Neuropathology of MS
3. The good and the bad of neuroinflammation in multiple sclerosis
4. Demyelination in multiple sclerosis
5. Axonal loss in multiple sclerosis: Causes and mechanisms
6. Insights from magnetic resonance imaging
7. Infections and multiple sclerosis
8. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment
Section 2 Epidemiology and genetics
9. Multiple sclerosis genetics
10. Genetics of primary progressive multiple sclerosis
11. The epidemiology of multiple sclerosis: insights to disease pathogenesis
Section 3 Diagnosis and disease course
12. Multiple Sclerosis: Diagnosis, differential diagnosis and clinical presentation
13. MRI mimics of multiple sclerosis
14. Diagnosis of multiple sclerosis
15. Clinical course of multiple sclerosis
16. Early prognosis of multiple sclerosis
17. Clinical outcome measures in multiple sclerosis
18. MRI outcomes in the diagnosis and disease course of multiple sclerosis
19. Multiple sclerosis in children
Section 4 Treatment
20. Clinical trials in multiple sclerosis
21. Glucocorticoid treatment of multiple sclerosis
22. Disease modifying agents in multiple sclerosis
23. Immunosuppressive treatments in multiple sclerosis
24. Symptomatic treatment and management of multiple sclerosis
25. Future treatment approaches to multiple sclerosis
Section 5 Other demyelinating diseases
26. Neuromyelitis optica (Devic's syndrome)
27. Acute disseminated encephalomyelitis and other inflammatory demyelinating variants
28. Acute inflammatory myelopathies
Section 6 Capita selecta
29. Clinical neurophysiology of multiple sclerosis
30. Cerebrospinal fluid analysis
